ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,498.40
      0.43%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      72.925
      -0.36%
      Bitcoin
      63,133.41
      0.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sutro Biopharma Inc (STRO) Quote

      Sutro Biopharma Inc

      Sutro Biopharma Inc (STRO)

      NASDAQ
      3.32
      -0.08
      (-2.35%)
      At close: September 25 4:00PM
      Delayed by 15 minutes
      3.32
      0.005
      ( 0.15% )
      After Hours: 4:10PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.32
      Bid
      3.35
      Ask
      3.76
      Volume
      1,649,827
      3.2215 Day's Range 3.45
      2.005 52 Week Range 6.13
      Market Cap
      272.119M
      Previous Close
      3.40
      Open
      3.40
      Last Trade
      5
      @
      3.31
      Last Trade Time
      Financial Volume
      $ 5,531,733
      VWAP
      3.3529
      Average Volume (3m)
      678,124
      Shares Outstanding
      81,963,659
      Dividend Yield
      -
      PE Ratio
      -2.54
      Earnings Per Share (EPS)
      -1.3
      Revenue
      153.73M
      Net Profit
      -106.79M

      About Sutro Biopharma Inc

      Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.sutrobio.com
      Headquarters
      South San Francisco, California, USA
      Founded
      -
      Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was $3.40. Over the last year, Sutro Biopharma shares have traded in a share price range of $ 2.005 to $ 6.13.

      Sutro Biopharma currently has 81,963,659 shares outstanding. The market capitalization of Sutro Biopharma is $278.68 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -2.54.

      Ask ADVFN Intelligence (AI)

      STRO Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      September 20 2024
      Edgar (US Regulatory)

      Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

      September 20 2024
      GlobeNewswire Inc.

      Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024

      - 4.3 mg/kg of luveltamab tazevibulin (luvelta) in combination with standard dose of bevacizumab (15 mg/kg) every 3 weeks resulted in a 56% objective response rate in patients with late-stage...

      September 14 2024
      GlobeNewswire Inc.

      Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024

      SOUTH SAN FRANCISCO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

      September 11 2024
      GlobeNewswire Inc.

      Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

      SOUTH SAN FRANCISCO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

      August 22 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 13 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 13 2024
      Edgar (US Regulatory)

      Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

      - Sutro will present updated data from the ongoing Phase 1b study of luvelta in combination with bevacizumab in a poster presentation at ESMO 2024; expansion study is ongoing with data expected in...

      August 13 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      August 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 12 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.69-17.20698254364.014.213.3157185673.68985098CS
      4-1.4-29.66101694924.724.82693.3156366234.1019816CS
      120.3712.54237288142.955.172.756781243.98629799CS
      26-0.08-2.352941176473.46.132.758339104.11972941CS
      520.030.9118541033433.296.132.0058230333.92780655CS
      156-15.84-82.672233820519.1623.72.0056110575.66113624CS
      260-6.66-66.73346693399.9828.32.0054790748.63143306CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RZLVRezolve AI Ltd
      $ 7.44
      (51.22%)
      		3.17M
      RNAZTransCode Therapeutics Inc
      $ 0.63
      (51.12%)
      		12.71M
      ATGLAlpha Technology Group Limited
      $ 2.16
      (49.72%)
      		3.41M
      INVZWInnoviz Technologies Ltd
      $ 0.18
      (45.69%)
      		11.02k
      OCTOEightco Holdings Inc
      $ 3.61
      (44.98%)
      		100.58M
      VTNRVertex Energy Inc
      $ 0.1501
      (-58.42%)
      		49.64M
      CMCTCreative Media and Community Trust Corporation
      $ 0.71
      (-54.63%)
      		3.56M
      SFIXStitch Fix Inc
      $ 2.28
      (-39.20%)
      		23.87M
      SHOTWSafety Shot Inc
      $ 0.22
      (-31.25%)
      		11.82k
      ARQQArqit Quantum Inc
      $ 4.40
      (-29.63%)
      		438.5k
      NVDANVIDIA Corporation
      $ 123.51
      (2.18%)
      		284.21M
      MLGOMicroAlgo Inc
      $ 0.2744
      (26.92%)
      		142.15M
      CEROCERo Therapeutics Holdings Inc
      $ 0.0986
      (5.23%)
      		123.48M
      SQQQProShares UltraPro Short QQQ
      $ 7.47
      (-2.35%)
      		123.42M
      INTCIntel Corporation
      $ 23.54
      (3.20%)
      		116.89M

      Discussion

      View Full Feed
      Backstabbed Backstabbed 3 minutes ago
      S1 cancellation soon? I don’t see an approved filing yet!
      DBGI
      titan11 titan11 3 minutes ago
      Just some Boston beans creatin some hot air!
      ASII
      Art67 Art67 3 minutes ago
      dead people live in past.
      WDLF
      1vman 1vman 4 minutes ago
      *****🅰️🅰️🅰️ WOW !!! 50 billion share authorized here

      PEE YEW stinky OTC pinky here

      https://www.otcmarkets.com/stock/UBQU/security

      ENOUGH SAID
      UBQU
      SSKILLZ1 SSKILLZ1 4 minutes ago
      VLN.TO Was the best performing stock pick today picked by MAXLUKE1. and the Best Top Pick was INTC picked by DEADJIM. hope this helps.
      INTC
      jealmc79 jealmc79 5 minutes ago
      Radiation poisoning.
      LWLG
      lakers17 lakers17 5 minutes ago
      Seriously or sarcasm? Court hearing and broadcast.
      NSAV
      Moonboy1 Moonboy1 5 minutes ago
      Does not dies
      GME
      europa7 europa7 5 minutes ago
      Researcher Exposes How SEC Views Speculation’s Role in XRP’s Utility
      25. September 2024
      https://www.crypto-news-flash.com/researcher-exposes-how-sec-views-speculations-role-in-xrps-utility/

      XRP Highlighted in SWIFT’s Recent Collaboration: What’s at Stake?
      24. Sept
      XRPUSD
      abew4me abew4me 5 minutes ago
      Join AirFuel Alliance and Energous Wireless Power Solutions on Tuesday, October 9th at 11 AM ET to discuss what the Energous 2W PowerBridge transmitter means for the future of IoT and wireless power technology (WPT).

      Discover how Energous 2W PowerBridge transmitter systems - and the
      WATT
      Moonboy1 Moonboy1 5 minutes ago
      Need a new CEO. Someone who wants to grow a new business and acquire others with all that cash. Not one who dies absolutely nothing
      GME
      tombe tombe 5 minutes ago
      Are we sure oct 7 is still happening?

      :23-cv-22221-KMW-AMD Document 24-2 Filed 09/24/24 Page 3 of 3 PageID: 1833 (2) that in view of the Court’s rulings that the asserted claims of the ’908 patent are invalid, judgment is granted in favor of Defendant on each of Plaintiffs’ clai
      AMD
      BirdsOfFire BirdsOfFire 6 minutes ago
      Thank you. Do you have a clue as to which company (candidate) will be the reverse merger?
      KGKG
      bigtalan bigtalan 6 minutes ago
      Yes along with a few more
      RSPI
      learningcurve2020 learningcurve2020 6 minutes ago
      She paid zero for those shares while receiving $500k to $1M in salary and also receiving likely tens of millions for Cognate deal while having another $100M UK pure play in the works.
      NWBO
      MetaMonster MetaMonster 6 minutes ago
      Super tight now rockafella
      RNAZ
      bowman88 bowman88 7 minutes ago
      You really are clueless haha. Carry on with your nonsense
      STHC
      1vman 1vman 7 minutes ago
      *****🅰️🅰️🅰️ HCMC Has had 5 reverse splits !!! PEE YEW stinky OTC pinky here

      ENOUGH SAID
      HCMC
      JusDePomme JusDePomme 7 minutes ago
      I saw asii .0006 ask100mil.....while bid only 10mil .0005 and someone slap 20mil .0006 ask get it going!
      AAPJ
      shoondale shoondale 8 minutes ago
      $MGON team can't be trusted to order coffee and donuts. And they expect us to buy stock in this scam?
      https://media4.giphy.com/media/v1.Y2lkPTc5MGI3NjExdDM5aTk1N3hwN2ZuOTUxcmNqaXlpd24ydjFqcXFzOHp6aHlidzZneSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/3o6Mb4B46MUGajPZ96/giphy.webp
      MGON
      janice shell janice shell 8 minutes ago
      Nope. He pled Not Guilty. Adding to the mystery...

      Your Recent History

      NASDAQ
      STRO
      Sutro Biopharma
      Delayed Upgrade Clock